Event website: www.lifescienceevents.com/path16
This is the FIRST live streamed only, three day professional conference discussing latest advances in methodologies for the cellular, molecular and digital analysis of disease.
This event will showcase the latest applications of multimodal pathological investigations used to study disease, and consider how current techniques can be improved for the benefit of healthcare management.
Dr Eric Thelin (Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden) will discuss the use of protein biomarkers to assess and monitor brain injury. Severe traumatic brain injuries are the most common cause of death for the young. Following impact, secondary detrimental brain injury development is common. In order to prevent this, patients are currently monitored using brain microdialysis and oxygen pressure probes. One of the drawbacks of these methods is the limited regionality.
Several centres have today introduced protein monitoring of bodily fluids for brain specific markers of tissue fate. By implementation of these protein markers in the standard multi-modal monitoring of unconscious patients suffering from different cerebral pathologies, it is possible to provide more global biomarkers of tissue fate and functional outcome (Dr Eric Thelin).
While Dr Cornelius Donat (Imperial College London, London, United Kingdom) will present work on new radioactive tracers of glia activation in the brain. Microglia and astrocyte activation is a response to the changes following brain injury and neurodegenerative diseases and is furthermore implied in neuropsychiatric disorders. Application of these radioligands in patients, employing minimally invasive Positron-Emission-Tomography, could help to understand the time course of inflammatory changes in these diseases better and provide monitoring options for new therapeutics (Dr Cornelius Donat).
Research within Dr Anant Madabhushi’s group has primarily focused on developing computational image analysis and machine learning tools and applying them to high dimensional imaging and pathology data. The discovery of these computationally derived image biomarkers is allowing physicians to predict which patients may be susceptible to a particular disease and also predicting disease outcome and survival. Dr Madabhushi’s group has pioneered the Ibris (image based risk score) which allows for computing a probability of disease aggressiveness based on features mined from medical images for a variety of cancers (Dr Anant Madabhushi, (Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA).
Who Should Attend: All those involved in pathological analysis and/or the development of novel analytical techniques, including researchers from academia and industry, laboratory technicians and clinicians.
The event will be recorded and available for all registered delegates up to a month after the event. So if you can’t manage all the days, or the different time zones, you can still have access to the full event.
A Euroscicon live streamed event gives you access to a wider range of international speakers at a fraction of the cost of a real world event. Furthermore, you no longer have to worry about travel or accommodation expenses, or any arrangements you have which clash with our events.
Invited speakers and their talks include
|Computational Imaging of Digital Pathology and Precision Medicine||Dr Anant Madabhushi||Case Western Reserve University||United States|
|Can Deep Learning Revolutionise Digital Pathology?||Dr Francesco Ciompi||Radboud University Medical Center||Netherlands|
|Complex pathological changes caused by blast injuries: Clinical reality & Experimental challenges||Dr Ibolja Cernak||University of Alberta||Canada|
|Talk title to be confirmed||Professor Ian A Cree||University Hospitals Coventry and Warwickshire||United Kingdom|
|How to use protein biomarkers to assess and monitor brain injury||Dr. Eric Thelin||Karolinska Institutet||Sweden|
|Organization and Implementation of Molecular Pathology Based Cervical Cancer Screening Program in Georgia||Professor Ekaterina Kldiashvili||New Vision University||Georgia|
|Radioligands for quantifying the glia response after brain injury and neuropsychiatric diseases.||Dr. Cornelius K. Donat||Imperial College London||United Kingdom|
|Can NSAIDs alter thyroid hormone function? Taking a multidisciplinary approach to address the off target effects of NSAIDs||Dr. Louise Mackenzie||University of Hertfordshire||United Kingdom|
|Comprehensive Immunohistochemistry: Digital, Analytical and Integrated||Dr. Arvydas Laurinavicius||Valstybinis patologijos centras||Lithuania|
|Nano-proteomic analysis technology: advancing quantitative proteomic research, biomarker assessment, and molecular profiling||Dr. Jinqiu Chen||National Cancer Institute||United States|
|Label-free Mueller matrix imaging of biological specimen for pathological applications||Professor Hui Ma||Tsinghua University||China|
Improving techniques and technology for cellular and molecular pathology has an open abstract session:
Abstracts can be submitted on any subject related to Pathology.
Advisory Board Members
|Mr. Marten Risling||Karolinska institutet||Sweden|
|Professor Marian Dmochowski||Poznan University of Medical Sciences||Poland|